Ying Huang

3PUBLICATIONS
3CO-AUTHORS
Molecular targetsHydrometallurgy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Mar 30, 2022
Discovery of the Clinical Candidate MAK683: An EED-Directed, Allosteric, and Selective PRC2 Inhibitor for the Treatment of Advanced Malignancies.

Ying Huang, Martin Sendzik, Jeff Zhang

|Jan 17, 2017
Discovery of First-in-Class, Potent, and Orally Bioavailable Embryonic Ectoderm Development (EED) Inhibitor with Robust Anticancer Efficacy.

Ying Huang, Jeff Zhang, Zhengtian Yu

|Dec 20, 2016
Structure-Guided Design of EED Binders Allosterically Inhibiting the Epigenetic Polycomb Repressive Complex 2 (PRC2) Methyltransferase.

Andreas Lingel, Martin Sendzik, Ying Huang

Pageof 1

Frequent Collaborators

3 joint publications

Andreas Lingel

1 joint publications

Xianghui Liu

1 joint publications

Carole Pissot-Soldermann